Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

Sotirios Bristogiannis, MD, Antonios Kattamis, MD, Dimitra Kyriakopoulou, MD, Maria Moraki, MD, Dimitrios Kountouras, MD PhD, Nikolaos Alexiou, MD

Blood (2016) 128 (22): 2471.

https://doi.org/10.1182/blood.V128.22.2471.2471

Published: 2016

Journal Articles

Increased T Follicular Helper Cells in Patients with Aplastic Anemia

Evgenia Verigou, MD PhD, Athanasios Galanopoulos, MD PhD, Antonios Kattamis, MD, Argiris Symeonidis, MD PhD, Elena E. Solomou, MD PhD

Blood (2016) 128 (22): 3907.

https://doi.org/10.1182/blood.V128.22.3907.3907

Published: 2016

Journal Articles

Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia and Sickle Cell Disease: Correlation with Renal Injury

Ioannis Papassotiriou, PhD, Voskaridou Ersi, MD, Alexandra Margeli, PhD, Theresa Nwagha, MD, Athanassia Kotrotsou, MD, Dimitra Kyriakopoulou, MD, Christos Poziopoulos, MD, Antonios Kattamis, MD

Blood (2014) 124 (21): 4078.

https://doi.org/10.1182/blood.V124.21.4078.4078

Published: 2014

Journal Articles

Combination Therapy of Deferasirox and Deferoxamine As Paregoric Treatment of Severe Iron Overload in Patients with Thalassemia Major

Vassilis Ladis, MD, Dimitra Kyriacopoulou, MD, Konstantinos Stokidis, MD, Aggeliki Moira, MD, Antonios Kattamis, MD

Blood (2012) 120 (21): 5181.

https://doi.org/10.1182/blood.V120.21.5181.5181

Published: 2012

Journal Articles

Thyroid Function in Greek Patients with Thalassemia Major

Polyxeni Delaporta, MD, Maria Karantza, MD, Sorina Boiu, MD, Konstantinos Stokidis, MD, Theoni Petropoulou, MD, Ioannis Papasotiriou, MD, Christos Kattamis, MD, Antonios Kattamis, MD

Blood (2012) 120 (21): 5176.

https://doi.org/10.1182/blood.V120.21.5176.5176

Published: 2012

Journal Articles

Correlation of NT-ProBNP Levels and Cardiac Iron Concentration in Patients with Transfusion-Dependent Thalassemia Major,

Antonios Kattamis, MD, Filia Apostolakou, Polyxeni Delaporta, MD, Ioannis Papassotiriou

Blood (2011) 118 (21): 3192.

https://doi.org/10.1182/blood.V118.21.3192.3192

Published: 2011

Journal Articles

Association of Endothelial Dysfunction and Angiogenesis in Patients with Thalassemia Intermedia

Ioannis Papassotiriou, PhD, Filia Apostolakou, Christina Lazaropoulou, BSc, Ino Kanavaki, MD, Effi Adamtziki, PhD, Ioannis Rombos, MD, Antonios Kattamis, MD

Blood (2011) 118 (21): 1084.

https://doi.org/10.1182/blood.V118.21.1084.1084

Published: 2011

Journal Articles

Iron Chelation Therapy in Transfusion Dependent Patients with Thalassemia and Minimal Liver Iron Load

Antonios Kattamis, MD, Konstantinos Stokidis, MD, Theoni Petropoulou, MD, Dimitra Kyriacopoulou, MD, Polyxeni Delaporta, MD, Ioannis Papassotiriou, PhD, Vassilis Ladis, MD

Blood (2010) 116 (21): 4270.

https://doi.org/10.1182/blood.V116.21.4270.4270

Published: 2010

Journal Articles

Variable Clinical Phenotype and Course In Greek Patients with Shwachman-Diamond Syndrome Carrying Identical SBDS Mutations

Polyxeni Delaporta, MD, Christalena Sofocleous, Stavros Doudounakis, MD, Marina Economou, MD, Emmanouil Kanavakis, MD, Antonios Kattamis, MD

Blood (2010) 116 (21): 4431.

https://doi.org/10.1182/blood.V116.21.4431.4431

Published: 2010

Journal Articles

The sFLT-1 to PlGF Ratio is Impaired in Patients with Thalassemia and Sickle Cell Disease.

Ioannis Papassotiriou, PhD, Alexandra Kouraklis-Symeonidis, MD, Filia Apostolakou, MSc, Athanassios Akalestos, BSc, Vlassis Vlazakis, MSc, Vassilios Ladis, MD, Antonios Kattamis, MD

Blood (2009) 114 (22): 2010.

https://doi.org/10.1182/blood.V114.22.2010.2010

Published: 2009

Journal Articles

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

Antonios Kattamis, MD, Christina Lazaropoulou, BSc, Maria Siopi, BSc, Ino Kanavaki, MD, Evgenios Goussetis, MD, Vassilios Ladis, MD, Ioannis Papassotiriou, PhD

Blood (2008) 112 (11): 5408.

https://doi.org/10.1182/blood.V112.11.5408.5408

Published: 2008

Journal Articles

Changes in MRI-Estimated Cardiac and Hepatic Iron Load in β-Thalassemia Patients Treated with Deferasirox at a Single Institution

Antonios Kattamis, MD, Panayiotis Moraitis, MD, Athanasia Lourida, MD, Efthemia Rigatou, MD, Vassilios Ladis, MD

Blood (2008) 112 (11): 5418.

https://doi.org/10.1182/blood.V112.11.5418.5418

Published: 2008

Journal Articles

Fluctuation of Cystatin C Concentration during Deferasirox Treatment in Thalassemic Patients May Reflect Hemodynamic Changes

Ioannis Papassotiriou, PhD, Antonios Kattamis, MD, Eugenia Hantzi, BSc, Polyxeni Delaporta, MD, Athanassia Sergounioti, MD, Alexandra Margeli, PhD, Vassilios Ladis, MD

Blood (2008) 112 (11): 5419.

https://doi.org/10.1182/blood.V112.11.5419.5419

Published: 2008

Journal Articles

Non-Transferrin-Bound Iron and Oxidative Stress Are Related to the Degree of Erythropoiesis in Patients with Thalassemia Intermedia.

Antonios Kattamis, MD, Christina Lazaropoulou, Emmanuel Kanavakis, MD, Vassilis Ladis, MD, George Paleologos, MD, Alexandra Stamoulakatou, MD, Christos Kattamis, MD, Ioannis Papassotiriou

Blood (2006) 108 (11): 1776.

https://doi.org/10.1182/blood.V108.11.1776.1776

Published: 2006

Journal Articles

Hepcidin Expression Is Correlated with Erythropoietic Indexes and Non-Transferrin-Bound Iron Levels in Patients with Thalassemia Major.

Antonios Kattamis, MD, Ioannis Papassotiriou, MD, Danai Palaiologou, Kalliopi Drakaki, MD, Filia Apostolopoulou, George Papanikolaou, MD

Blood (2005) 106 (11): 2693.

https://doi.org/10.1182/blood.V106.11.2693.2693

Published: 2005

Journal Articles

Possible Neuroprotective Effect of Erythropoietin in Acute Inflammation Induced by Exhaustive Exercise.

Ioannis Papassotiriou, PhD, Maria Tsironi, MD, Evangelos Premetis, PhD, Katerina Kariyannis, BSc, Katerina Skenderi, PhD, Alexandra Stamoulakatou, MD, Antonios Kattamis, MD, George Chrousos, MD

Blood (2005) 106 (11): 4259.

https://doi.org/10.1182/blood.V106.11.4259.4259

Published: 2005

Journal Articles

Safety and Efficacy of Alternate Desferrioxamine and Deferiprone Compared to Desferrioxamine Alone in the Treatment of Iron Overload in Transfusion-Dependent Thalassemia Patients.

Renzo Galanello, MD, Antonios Kattamis, MD, Antonio Piga, MD, Fernando Tricta, MD

Blood (2004) 104 (11): 3611.

https://doi.org/10.1182/blood.V104.11.3611.3611

Published: 2004

Journal Articles

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

Maria Cappellini, MD, Mohamed Bejaoui, MD, Silverio Perrotta, MD, Leyla Agaoglu, MD, Antonios Kattamis, MD, Patricia Giardina, MD, Gritta Janka-Schaub, MD, Herbert Opitz, PhD, Catherine Ressayre-Djaffer, PhD, Daniele Alberti, MD

Blood (2004) 104 (11): 3619.

https://doi.org/10.1182/blood.V104.11.3619.3619

Published: 2004

Journal Articles

The Incidence of Thromboembolic Events among 8860 Patients with Thalassemia Major and Intermedia in the Mediterranean Area and Iran.

Ali Taher, MD, Ghassan Mehio, MD, Daniela Bignamini, MD, Antonios Kattamis, MD, Eliezer Rachmilewitz, MD, Maria Cappellini, MD

Blood (2004) 104 (11): 3623.

https://doi.org/10.1182/blood.V104.11.3623.3623

Published: 2004

NARROW

The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

Increased T Follicular Helper Cells in Patients with Aplastic Anemia

Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia and Sickle Cell Disease: Correlation with Renal Injury

Combination Therapy of Deferasirox and Deferoxamine As Paregoric Treatment of Severe Iron Overload in Patients with Thalassemia Major

Thyroid Function in Greek Patients with Thalassemia Major

Correlation of NT-ProBNP Levels and Cardiac Iron Concentration in Patients with Transfusion-Dependent Thalassemia Major,

Association of Endothelial Dysfunction and Angiogenesis in Patients with Thalassemia Intermedia

Iron Chelation Therapy in Transfusion Dependent Patients with Thalassemia and Minimal Liver Iron Load

Variable Clinical Phenotype and Course In Greek Patients with Shwachman-Diamond Syndrome Carrying Identical SBDS Mutations

The sFLT-1 to PlGF Ratio is Impaired in Patients with Thalassemia and Sickle Cell Disease.

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

Changes in MRI-Estimated Cardiac and Hepatic Iron Load in β-Thalassemia Patients Treated with Deferasirox at a Single Institution

Fluctuation of Cystatin C Concentration during Deferasirox Treatment in Thalassemic Patients May Reflect Hemodynamic Changes

Non-Transferrin-Bound Iron and Oxidative Stress Are Related to the Degree of Erythropoiesis in Patients with Thalassemia Intermedia.

Hepcidin Expression Is Correlated with Erythropoietic Indexes and Non-Transferrin-Bound Iron Levels in Patients with Thalassemia Major.

Possible Neuroprotective Effect of Erythropoietin in Acute Inflammation Induced by Exhaustive Exercise.

Safety and Efficacy of Alternate Desferrioxamine and Deferiprone Compared to Desferrioxamine Alone in the Treatment of Iron Overload in Transfusion-Dependent Thalassemia Patients.

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

The Incidence of Thromboembolic Events among 8860 Patients with Thalassemia Major and Intermedia in the Mediterranean Area and Iran.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only